CERENOME, INC. Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants
CERENOME, INC. (CNSY) reported Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants of 300.00 thousand shares for the 3-month period ending 2015-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Income Statement › Earnings Per Share
us-gaap:IncrementalCommonSharesAttributableToCallOptionsAndWarrants · last filed 2016-11-09
- CERENOME, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2015-09-30 was 300.00K shares.
- CERENOME, INC. incremental common shares attributable to dilutive effect of call options and warrants for the quarter ending 2015-06-30 was 600.00K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants 3 month as first filed |
|---|---|---|
| 2015-09-30 | 300.00K shares 10-Q · filed 2016-11-09 | 4.20M shares 10-Q · filed 2015-11-06 |
| 2015-06-30 | 600.00K shares 10-Q · filed 2016-08-05 | 8.40M shares 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |